SEHCAT DIN 02329050
Health Canada record
| Active ingredient(s) | TAUROSELCHOLIC ACID (75SE) 370 KBq |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09DX01 SELENIUM 75 SE TAUROSELCHOLIC ACID |
| Original market date | 18-Feb-1985 |
| Current status date | 14-Apr-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
GE Healthcare Canada Inc. — licence 101469, currently licensed, last inspection rating C (2023-02-06).
No Canadian shortage report is currently matched to this DIN.
Request a quote for SEHCAT